Walking down a hallway at the headquarters of Singapore health care company Cordlife, Chief Executive Jeremy Yee points to plaques commemorating 18 successful stem-cell infusions over its 14-year history. Georgia Conn’s cerebral palsy has improved after getting blood from her own umbilical cord when she was 2 years old. One 16-year-old is now in remission from leukemia, thanks to receiving his sister’s cord blood. “The odds of fighting off disease in a family are much higher if you store your own cord blood,” says Yee. “Our strategy is to empower everyone to store.”